Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2003
05/29/2003US20030099709 Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
05/29/2003US20030099708 Printing or dispensing a suspension such as three-dimensional printing of dosage forms
05/29/2003US20030099705 Sustained release ranolazine formulations
05/29/2003US20030099704 Controlled release oxycodone compositions
05/29/2003US20030099703 Drug-containing solid dispersion having improved solubility
05/29/2003US20030099700 Orodispersible tablets, able to disintegrate in buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, containing fexofenadine or its salt in the form of a coated granule, and excipients
05/29/2003US20030099699 Storage stable thyroxine active drug formulations and methods for their production
05/29/2003US20030099697 Amphoteric liposomes and their use
05/29/2003US20030099695 Stabilised oversaturated transdermal therapeutical matrix systems
05/29/2003US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers
05/29/2003US20030099692 Oral film which contains starch as main component; useful for delivering a variety of agents to humans and other animals
05/29/2003US20030099691 Films containing starch
05/29/2003US20030099675 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery
05/29/2003US20030099674 Comprising porous lyophilized formulation containing at least one taxoid drug, wherein formulation can be readily reconstituted into injectable suspension or emulsion by mixing with water using mild agitation
05/29/2003US20030099666 Gum resin as a carrier for topical application of pharmacologically active agents
05/29/2003US20030099662 Proteins
05/29/2003US20030099659 Comprises glycerides for mucosal administration; provides enhanced adhesion and absorption
05/29/2003US20030099658 For high speed detection, selection, isolation, and targeting; comprises beta-lactam antibiotics
05/29/2003US20030099657 Drug-heteropolymers
05/29/2003US20030099655 Humanized collagen antibodies and related methods
05/29/2003US20030099640 Three-step pretargeting methods and compounds
05/29/2003US20030099628 Preventing proliferation of a tumor, using heparinase III; use sequencing heparin-like glycosaminoglycans (HLGAGs), removing active heparan sulfate from a solution, inhibition of angiogenesis
05/29/2003US20030099613 An encoded repressor or activator and a viral nucleotide sequence for replication; preparing a vaccine for the prophylaxis of AIDS, human immunodeficiency virus
05/29/2003US20030099606 Iodinating an strong base anion exchange resin with iodine or an iodine compound; abosorbing through the pores of ion exchange resin
05/28/2003EP1314743A2 Low amylose and adipate crosslinked tapioca starch
05/28/2003EP1314437A1 Stabilized antibody-containing preparations
05/28/2003EP1314436A4 Antiviral agent in the form of nose drops
05/28/2003EP1314436A1 Antiviral agent in the form of nose drops
05/28/2003EP1314428A1 Oct preparations
05/28/2003EP1314422A2 Orally disintegrating solid preparations and processes for the production thereof
05/28/2003EP1313820A2 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives
05/28/2003EP1313794A2 Elastomeric functional biodegradable copolyester amides and copolyester urethanes
05/28/2003EP1313772A1 New cross-linked derivatives of hyaluronic acid
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313738A1 Process for the preparation and purification of thiol-containing maytansinoids
05/28/2003EP1313513A2 Identification, diagnosis, and treatment of breast cancer
05/28/2003EP1313511A2 Testosterone ester formulation for human use
05/28/2003EP1313510A2 Novel pharmaceutical composition
05/28/2003EP1313498A2 Phospholipase d effectors for therapy and screening
05/28/2003EP1313490A1 Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara
05/28/2003EP1313489A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
05/28/2003EP1313482A1 Pharmaceutical composition and method for treating hypogonadism
05/28/2003EP1313481A1 Pharmaceutical composition comprising condensed indole compound
05/28/2003EP1313479A1 Hair loss prevention
05/28/2003EP1313474A2 Paroxetine compositions and processes for making the same
05/28/2003EP1313473A2 Sustained release formulations for growth hormone secretagogues
05/28/2003EP1313467A2 Novel pharmaceutical composition for administering n-0923
05/28/2003EP1313457A1 Transdermal therapeutic system for releasing venlafaxine
05/28/2003EP1313456A2 Intradermal-penetration agents for topical local anesthetic administration
05/28/2003EP1313454A2 Polymeric compositions and a method of making the same
05/28/2003EP1313453A1 Particulate vectors for improving oral absorption of active principles
05/28/2003EP1313451A2 Milled particles
05/28/2003EP1313449A2 Amphotericin b structured emulsion
05/28/2003EP1313446A1 Water soluble microflake through air-gap and process therefore
05/28/2003EP1313442A2 Storage stable tretinoin and 4-hydroxy anisole containing topical composition
05/28/2003EP1278412A4 Polymer conjugates of ara-c and ara-c derivatives
05/28/2003EP1243275A4 Insulin-containing medicament for peroral application and method for the production thereof
05/28/2003EP1203002B1 Process for preparing a charcoal-gm1 complex
05/28/2003EP1140035B1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same
05/28/2003EP1128810B1 Drug delivery device, especially for the delivery of androgens
05/28/2003EP1115478A4 Emollient esters based upon capryl alcohol and isostearic acid
05/28/2003EP1105114B1 Nimesulide containing topical pharmaceutical compositions
05/28/2003EP1067916B1 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
05/28/2003EP1066049B1 Pharmaceutical compositions for prolonged peptide release and preparation method
05/28/2003EP0941100B1 Pharmaceutical compositions containing lamivudine and zidovudine
05/28/2003EP0939641B1 Topical products as prophylactic or curative agents for bacterial skin infections
05/28/2003EP0859612B1 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation
05/28/2003EP0822819B1 Solvent detergent emulsions having antiviral activity
05/28/2003EP0814833B1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
05/28/2003EP0797430B1 Foamable formulation and foam
05/28/2003EP0748215B1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
05/28/2003EP0668759B1 Transdermal delivery of ketorolac
05/28/2003CN1420934A Targeted artificial gene delivery
05/28/2003CN1420924A Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof
05/28/2003CN1420893A Method and compositions for generating human monoclonal antibodies
05/28/2003CN1420790A Transporters and drug delivery system by using same
05/28/2003CN1420789A Compound for targeting
05/28/2003CN1420787A Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
05/28/2003CN1420786A Treatment of fungal infections with beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
05/28/2003CN1420784A Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof
05/28/2003CN1420777A Pharmaceutical compositions and preparations for treatment of metabolic bone disease
05/28/2003CN1420774A Sustained release beadlets conty. stavudine
05/28/2003CN1420771A Hydrophilic molecular disperse solutions of carvedilol
05/28/2003CN1420766A Partial fatty acid oxidation inhibitors in treatment of congestive heart failure
05/28/2003CN1420765A Method for chemoprevention of prostate cancer
05/28/2003CN1420763A Orally administered controlled delivery system for once daily administration of ciprofloxacin
05/28/2003CN1420762A Devices for delivery of drugs having antiprogestinic properties
05/28/2003CN1420761A Composition for inhalation comprising delta-9-tetrahydrocannabinol in semiaqueous solvent
05/28/2003CN1420755A Method and composition for treatment of scars
05/28/2003CN1420140A Thin film contg. starch
05/28/2003CN1419940A Medical ointment, film and tincture
05/28/2003CN1419911A Sucros ester-C20-28 alcohol preparation
05/28/2003CN1109558C Stabilized pharmaceutical peptide compositions
05/28/2003CN1109557C Cetroretix lyophilisate and process for preparation thereof
05/28/2003CN1109542C Improved nicotine lozenge and therapeutic method for smoking cessation
05/27/2003US6570024 N-methyl-L-alanine derivatives derivatives used for preparing cell binding agent/maytansinoid complexes
05/27/2003US6569906 Composition containing a precursor capable of being hydrolysed by glucocerebrosidase
05/27/2003US6569841 Administering a dextran that has been modified by covalent bonding of charged groups opposite that of a charged tumor
05/27/2003US6569661 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
05/27/2003US6569528 Amphiphilic biodegradable block copolymers and self-assembled polymer aggregates formed from the same in aqueous milieu
1 ... 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 ... 1712